| Randomized trial of a meditation-based stress reduction program and cognitive behavior therapy in generalized social anxiety disorder D Koszycki, M Benger, J Shlik, J Bradwejn Behaviour Research and Therapy 45 (10), 2518-2526, 2007 | 535 | 2007 |
| International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors F Noble, SA Wank, JN Crawley, J Bradwejn, KB Seroogy, M Hamon, ... Pharmacological reviews 51 (4), 745-781, 1999 | 512 | 1999 |
| Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings J Bradwejn, D Koszycki, C Shriqui Archives of general psychiatry 48 (7), 603-610, 1991 | 420 | 1991 |
| CCK in animal and human research on anxiety J Harro, E Vasar, J Bradwejn Trends in pharmacological sciences 14 (6), 244-249, 1993 | 348 | 1993 |
| Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial H Bissada, GA Tasca, AM Barber, J Bradwejn American Journal of Psychiatry 165 (10), 1281-1288, 2008 | 337 | 2008 |
| Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder J Bradwejn, D Koszycki, G Meterissian The Canadian Journal of Psychiatry 35 (1), 83-85, 1990 | 329 | 1990 |
| A multifaith spiritually based intervention for generalized anxiety disorder: A pilot randomized trial D Koszycki, K Raab, F Aldosary, J Bradwejn Journal of clinical psychology 66 (4), 430-441, 2010 | 245 | 2010 |
| Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers. C Benkelfat, J Bradwejn, E Meyer, M Ellenbogen, S Milot, A Gjedde, ... The American journal of psychiatry 152 (8), 1180-1184, 1995 | 234 | 1995 |
| Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones J Bradwejn, C de Montigny Nature 312 (5992), 363-364, 1984 | 233 | 1984 |
| A double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects J Bradwejn, Y Zhou, D Koszycki, J Shlik Journal of clinical psychopharmacology 20 (6), 680-684, 2000 | 218 | 2000 |
| The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder J Bradwejn, D Koszycki, AC du Tertre, H van Megen, J Den Boer, ... Archives of general psychiatry 51 (6), 486-493, 1994 | 206 | 1994 |
| Investigation of cholecystokinin system genes in panic disorder JL Kennedy, J Bradwejn, D Koszycki, N King, R Crowe, J Vincent, ... Molecular psychiatry 4 (3), 284-285, 1999 | 184 | 1999 |
| Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points M Javanmard, J Shlik, SH Kennedy, FJ Vaccarino, S Houle, J Bradwejn Biological psychiatry 45 (7), 872-882, 1999 | 178 | 1999 |
| Fetal gender and postpartum depression in a cohort of Chinese women R Xie, G He, A Liu, J Bradwejn, M Walker, SW Wen Social science & medicine 65 (4), 680-684, 2007 | 162 | 2007 |
| A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder. MR Liebowitz, RM Mangano, J Bradwejn, G Asnis, SAD Study Group Journal of Clinical Psychiatry 66 (2), 238-247, 2005 | 160 | 2005 |
| Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study J Bradwejn, A Ahokas, DJ Stein, E Salinas, G Emilien, T Whitaker The British Journal of Psychiatry 187 (4), 352-359, 2005 | 149 | 2005 |
| Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients. J Bradwejn, D Koszycki The American journal of psychiatry 151 (2), 261-263, 1994 | 148 | 1994 |
| Neurobiology of panic disorder M Bourin, GB Baker, J Bradwejn Journal of Psychosomatic Research 44 (1), 163-180, 1998 | 141 | 1998 |
| Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study. CL Shriqui, J Bradwejn, L Annable, BD Jones The American journal of psychiatry 149 (3), 391-393, 1992 | 127 | 1992 |
| The cholecystokinin hypothesis of anxiety and panic disorder J Bradwejn, D Koszycki Annals of the New York Academy of Sciences-Paper Edition 713, 273-282, 1994 | 126 | 1994 |
Guy Chouinardprofessor of psychiatry and medicine,Researcher Emeritus, Research Center University Mental HealthOverená e-mailová adresa na: umontreal.ca